MaxWell Biosciences
Business Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3809 Juniper Trce Ste 102, Austin, Texas...Website
www.maxwellbiosciences.comRevenue
$6.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About MaxWell Biosciences
Maxwell Biosciences is a biotechnology company developing novel anti-infective therapeutics inspired by nature, using biomimetic peptides to target viruses, bacteria, and other pathogens with a unique, resistance-free mechanism.Explore more
MaxWell Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MaxWell Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if MaxWell Biosciences had a recent Job posting/layoffs
Product Launch: Get notified when MaxWell Biosciences launches new products
Earning: See what the market has to say on MaxWell Biosciences recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if MaxWell Biosciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at MaxWell Biosciences
Check if MaxWell Biosciences has recently received funding, and reach out quickly before it becomes old news!
MaxWell Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once MaxWell Biosciences has new funding data
Recommended Actions
Find VP level buyers at MaxWell Biosciences
Find 2 more new buyers
Compare Similar Companies to MaxWell Biosciences
Compare insights from companies similar to MaxWell Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$123.9M
51-200
Public
$462.1M
1994
TC
Tracy ClementeChief People Officer & Chief Human Resources Officer
Company Profile Activity
Activity Insights
MaxWell Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
MaxWell Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about MaxWell Biosciences.
MaxWell Biosciences financials insights
Gather financial insights about MaxWell Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$20M
MaxWell Biosciences Tech Stack
A closer look at the technologies used by MaxWell Biosciences
Most Recent Scoops
Funding
Funding
New Hire
Executive Move
New Hire
Executive Move
New Hire
Executive Move
New Hire
Executive Move
MaxWell Biosciences News & Media
Maxwell Biosciences Announces Appointment of José Antonio Alas to Its Board of Directors
Appointment of José Antonio Alas brings more than 30 years of biotech expertise, including global business development, international partnerships, patient access to innovative medications and product launches as the company advances its Claromer drug discovery platformMaxwell Biosciences Announces Promising Activity of Claromer Compound Against Ebola Virus in a Research Study
Austin, Texas--(Newsfile Corp. - November 2, 2023) - Maxwell Biosciences, Inc., (MXB) a pre-clinical drug platform company focused on developing biomimetic therapeutics that improve upon natural immune system peptides based on its patented Claromer® technology platform, today announced that it has received promising data on activity against Ebola virus from a study conducted in collaboration with NIH-NIAID's Rocky Mountain Laboratories (RML). RML is one of the few Biosafety Level (BSL) 4 labs inMaxwell Biosciences Enters CRADA with USAMRIID to Test Claromer Compounds as Potential Therapeutics for Viral Pathogens, Including Hemorrhagic Fever Ebola Viral Disease, and Other Biodefense Pathogens
Austin, Texas--(Newsfile Corp. - October 25, 2023) - Maxwell Biosciences, a pre-clinical drug platform company focused on developing biomimetic therapeutics that improve upon natural immune system peptides based on its patented Claromer® technology platform, today announced that they have entered into a Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (U.S. Army Medical Research Institute of Infectious Diseases..Maxwell Biosciences Appoints Major General (Ret.) Barb Holcomb, RN, BSN, MSN to Its Board of Directors
Austin, Texas--(Newsfile Corp. - October 18, 2023) - Maxwell Biosciences ("Maxwell"), a preclinical drug platform company developing a synthetic immune system that may serve as a key biodefense asset, today announced the appointment of Major General (Retired) Barb Holcomb, RN, BSN, MSN to its Board of Directors. This appointment adds one of the world's top national security and biodefense research and logistics executives to Maxwell's board.General Holcomb's leadership is instrumental in...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding MaxWell Biosciences
Sign Up For FreeTo access detailed company insights
Maxwell Biosciences is a biotechnology company developing novel anti-infective therapeutics inspired by nature, using biomimetic peptides to target viruses, bacteria, and other pathogens with a unique, resistance-free mechanism.... Read More
